MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Editas Medicine Company Profile (NASDAQ:EDIT)

Consensus Ratings for Editas Medicine (NASDAQ:EDIT) (?)
Ratings Breakdown: 2 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $33.33 (5.36% downside)

Analysts' Ratings History for Editas Medicine (NASDAQ:EDIT)
Show:
DateFirmActionRatingPrice TargetActions
5/16/2016Cowen and CompanyReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/29/2016Morgan StanleyInitiated CoverageEqual -> Equal Weight$28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/29/2016JPMorgan Chase & Co.Initiated CoverageNeutral$32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/29/2016JMP SecuritiesInitiated CoverageOutperform$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/30/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha